References
- Wells JM, Brummer RJ, Derrien M, et al. Homeostasis of the gut barrier and potential biomarkers. Am J Physiol Gastrointest Liver Physiol. 2017;312(3):G171–G193. doi:https://doi.org/10.1152/ajpgi.00048.2015.
- Meddings J. The significance of the gut barrier in disease. Gut. 2008;57(4):438–440. doi:https://doi.org/10.1136/gut.2007.143172.
- Balmer ML, Slack E, de Gottardi A, et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med. 2014;6:237–266.
- Spadoni I, Zagato E, Bertocchi A, et al. A gut-vascular barrier controls the systemic dissemination of bacteria. Science. 2015;350(6262):830–834. doi:https://doi.org/10.1126/science.aad0135.
- Liebner S, Corada M, Bangsow T, et al. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol. 2008;183(3):409–417. doi:https://doi.org/10.1083/jcb.200806024.
- Daneman R, Rescigno M. The gut immune barrier and the blood-brain barrier: are they so different? Immunity. 2009;31(5):722–735. doi:https://doi.org/10.1016/j.immuni.2009.09.012.
- Thomas H. Intestinal tract: gut endothelial cells-another line of defence. Nat Rev Gastroenterol Hepatol. 2016;13(1):4. doi:https://doi.org/10.1038/nrgastro.2015.205.
- Dempsey LA, Fehervari Z, Visan I. A gut vascular barrier. Nat Immunol. 2016;17(1):47–47.
- Bouziat R, Jabri B. Immunology. Breaching the gut-vascular barrier. Science. 2015;350(6262):742–743. doi:https://doi.org/10.1126/science.aad6768.
- Ungaro F, Tacconi C, D'Alessio S. Beyond intestinal barrier: the blood endothelium as a second wall of defense against bacterial invasion. Gastroenterology. 2016;150(7):1678–1680. doi:https://doi.org/10.1053/j.gastro.2016.04.024.
- Spadoni I, Pietrelli A, Pesole G, Rescigno M. Gene expression profile of endothelial cells during perturbation of the gut vascular barrier. Gut Microbes. 2016;7(6):540–548. doi:https://doi.org/10.1080/19490976.2016.1239681.
- Jurisic G, Maby-El Hajjami H, Karaman S, et al. An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation. Circ Res. 2012;111(4):426–436. doi:https://doi.org/10.1161/CIRCRESAHA.112.269399.
- Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:https://doi.org/10.1093/nar/gkv007.
- Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:https://doi.org/10.1089/omi.2011.0118.
- Aird WC. Endothelial cell heterogeneity. Cold Spring Harb Perspect Med. 2012;2(1):a006429. doi:https://doi.org/10.1101/cshperspect.a006429.
- Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease – a 30th anniversary update. Acta Physiol (Oxf)). 2017;219(1):22–96. doi:https://doi.org/10.1111/apha.12646.
- Cho JG, Lee A, Chang W, Lee MS, Kim J. Endothelial to mesenchymal transition represents a key link in the interaction between inflammation and endothelial dysfunction. Front Immunol. 2018;9:294. doi:https://doi.org/10.3389/fimmu.2018.00294.
- Gravina AG, Dallio M, Masarone M, et al. Vascular endothelial dysfunction in inflammatory bowel diseases: pharmacological and nonpharmacological targets. Oxid Med Cell Longev. 2018;2018:2568569. doi:https://doi.org/10.1155/2018/2568569.
- Danese S, Semeraro S, Marini M, et al. Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation. Dig Liver Dis. 2005;37(11):811–818. doi:https://doi.org/10.1016/j.dld.2005.03.013.
- Cibor D, Domagala-Rodacka R, Rodacki T, Jurczyszyn A, Mach T, Owczarek D. Endothelial dysfunction in inflammatory bowel diseases: pathogenesis, assessment and implications. World J Gastroenterol. 2016;22(3):1067–1077. doi:https://doi.org/10.3748/wjg.v22.i3.1067.
- Danese S, Fiocchi C. Endothelial cell-immune cell interaction in IBD. Dig Dis. 2016;34(1-2):43–50. doi:https://doi.org/10.1159/000442925.
- Cromer WE, Mathis JM, Granger DN, Chaitanya GV, Alexander JS. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol. 2011;17(5):578–593. doi:https://doi.org/10.3748/wjg.v17.i5.578.
- Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39–51. doi:https://doi.org/10.1016/j.cell.2010.03.014.
- Wolf MJ, Hoos A, Bauer J, et al. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell. 2012;22(1):91–105. doi:https://doi.org/10.1016/j.ccr.2012.05.023.
- Qian BZ, Li J, Zhang H, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475(7355):222–225. doi:https://doi.org/10.1038/nature10138.
- Reymond N, d'Água BB, Ridley AJ. Crossing the endothelial barrier during metastasis. Nat Rev Cancer. 2013;13(12):858–870. doi:https://doi.org/10.1038/nrc3628.
- Wragg JW, Finnity JP, Anderson JA, et al. MCAM and LAMA4 are highly enriched in tumor blood vessels of renal cell carcinoma and predict patient outcome. Cancer Res. 2016;76(8):2314–2326. doi:https://doi.org/10.1158/0008-5472.CAN-15-1364.